Fund Universe

Krensavage Asset Management, LLC

CIK 0001609251 · holdings for 2026Q2 (change vs 2026Q1) · in signal universe
Quality Q
0.683
AUM ($M)
263
Positions
18
Turnover
0.14
Top-10 wt
89%
Herfindahl
0.103
History (qtrs)
6
Excess Return

AI Eval Run AI Eval

No AI Eval requested yet for this fund.
Quarter
Activity this period
Security type

Holdings · 20 positions · portfolio value $263M

TickerNameActivitySecurity Type WeightΔ Weight Value ($M)SharesΔ Shares Qtrs HeldExcess Return
ENTA funds › ENANTA PHARMACEUTICALS INC HOLD 15.9% +1.7% 41.8 2,866,138 +0 5
JAZZ funds › JAZZ PHARMACEUTICALS PLC HOLD 15.4% +3.0% 40.4 167,816 +0 5
UTHR funds › UNITED THERAPEUTICS CORP TRIM 14.3% -5.3% 37.5 69,282 -15,000 5
BMRN funds › BIOMARIN PHARMACEUTICAL INC HOLD 11.4% -0.2% 30.0 524,786 +0 4
EXEL funds › EXELIXIS INC TRIM 7.7% +0.7% 20.2 370,693 -45,000 5
ABT funds › ABBOTT LABORATORIES ADD 6.9% +6.7% 18.1 200,000 +195,000 2
SNY funds › SANOFI-ADR HOLD 5.3% -0.9% 13.8 323,946 +0 5
SUPN funds › SUPERNUS PHARMACEUTICALS INC HOLD 5.0% -0.7% 13.1 280,681 +0 5
RARE funds › ULTRAGENYX PHARMACEUTICAL IN HOLD 5.0% +1.8% 13.1 390,879 +0 3
VNDA funds › VANDA PHARMACEUTICALS INC HOLD 2.7% -0.4% 7.2 1,180,388 +0 5
BNTX funds › BIONTECH SE-ADR HOLD 2.1% +0.0% 5.5 59,523 +0 5
GSK funds › GSK PLC-SPON ADR HOLD 1.9% -0.2% 5.1 96,729 +0 5
BIIB funds › BIOGEN INC HOLD 1.6% +0.2% 4.3 20,000 +0 4
REGN funds › REGENERON PHARMACEUTICALS ADD 1.4% +0.2% 3.7 6,000 +2,000 5
EMBC funds › EMBECTA CORP ADD 1.4% -1.1% 3.7 1,135,340 +400,000 2
ARDX funds › ARDELYX INC ADD 1.0% -0.1% 2.7 534,523 +34,523 2
INMD funds › INMODE LTD HOLD 0.7% +0.0% 1.8 120,942 +0 2
EOLS funds › EVOLUS INC HOLD 0.4% +0.2% 1.1 157,985 +0 4
INDV funds › INDIVIOR PHARMACEUTICALS INC EXIT 0.0% -4.0% 0.0 0 -339,532 0
ALKS funds › ALKERMES PLC EXIT 0.0% -1.5% 0.0 0 -107,822 0

Point-in-time history

Each row is this fund as of that period, not as of today — what the scoring for that quarter actually saw.
PeriodAUM ($M)Positions TurnoverTop-10 wtHerfindahl Quality Q Skill Universe
2026Q2 263 18 0.14 89% 0.103 0.682 in
2026Q1 256 20 0.20 87% 0.105 0.560 in
2025Q4 283 18 0.11 87% 0.095 0.700 in
2025Q3 235 17 0.19 86% 0.090 0.505 in
2025Q2 189 15 0.12 86% 0.090 0.652 entered
2025Q1 181 14 0.00 90% 0.109 0.000 out
Long US-equity 13F disclosures only · up to 45-day reporting lag · sells = reduce/avoid, not short. JSON: /api/signals · /api/funds · /api/status